Literature DB >> 9456

Adrenergic mechanisms and the adenyl cyclase system in atopic dermatitis.

C E Reed, W W Busse, T P Lee.   

Abstract

Patients with atopic dermatitis have abnormal autonomic responses of the arterioles, pilomotor smooth muscle, and sweat glands. Their lesions have been reported to contain increased amounts of the neurohumors, acetylcholine and norepinephrine, as well as increased activity of acetylcholinesterase and catechol-O-methyltransferase. In vitro studies of epidermis show that beta adrenergic agonists fail to evoke the normal inhibition of mitosis of basal cells of patients with atopic dermatitis. Epidermis removed not only from the lesions, but also from normal-appearing skin, responded abnormally. The increase in intracellular levels of cAMP after exposure to catecholamines was similar in normal and atopic epidermis. Lymphocytes and PMN leukocytes isolated from patients with atopic dermatitis show both a decreased physiologic response (glycogenolysis and inhibition of lysosome enzyme release) and a decreased rise in intracellular levels of cAMP upon incubation with beta agonists, but a normal response to PGE1. Cortisol increases the response of lymphocyte adenyl cyclase to both agonists and, in the case of the patients with atopic disease, more than overcomes the depressed response to beta agonists. Because the leukocytes respond normally to PGE1 and because others have reported normal activities of skin and adenyl cyclase, phosphodiesterase, and protein kinases, we conclude that the step responsible for the diminished beta adrenergic response lies antecedent to the catalytic site of adenyl cyclase.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 9456     DOI: 10.1111/1523-1747.ep12514494

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  4 in total

Review 1.  Beta adrenergic receptors in keratinocytes.

Authors:  Raja K Sivamani; Susanne T Lam; R Rivkah Isseroff
Journal:  Dermatol Clin       Date:  2007-10       Impact factor: 3.478

Review 2.  Immune mechanisms in atopic dermatitis.

Authors:  D Y Leung; R S Geha
Journal:  Springer Semin Immunopathol       Date:  1981

Review 3.  Pharmacophysiology of atopic dermatitis.

Authors:  J M Hanifin
Journal:  Clin Rev Allergy       Date:  1986-02

4.  β-Adrenergic Receptor Trafficking, Degradation, and Cell Surface Expression Are Altered in Dermal Fibroblasts from Hypertrophic Scars.

Authors:  Amina El Ayadi; Anesh Prasai; Ye Wang; David N Herndon; Celeste C Finnerty
Journal:  J Invest Dermatol       Date:  2018-02-22       Impact factor: 8.551

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.